Both are affordable clinics with different strengths. PeterMD wins on longevity drugs and track record. Limitless Alt Med wins on BPC-157, PT-141, oral TRT, free consultations, and peptide access without bloodwork.
| PeterMD | Limitless Alt Med | |
|---|---|---|
| BPC-157 | Not offered | $325 injectable |
| PT-141 | Not offered | $184 |
| GHK-Cu | Not offered | Yes — blends |
| Sermorelin | $211/mo (1-mo) · $585 (3-mo) | $194 published |
| NAD+ | $125/mo | $180/vial |
| Metformin / Rapamycin | Yes — longevity protocols | Not offered |
| TRT | From $77/mo annual | $115–$170/mo, oral + injectable |
| GLP-1 (Sema) | $165/mo ongoing | Sublingual $200 |
| Consultation | Included in plan | Free |
| Labs Required? | $95 for TRT | 95% no bloodwork required |
| Oral TRT | — | Yes |
| Trustpilot | 4.8–5.0/5 (13,900+ reviews) | — |
| Full Review | Read PeterMD Review → | Read Limitless Review → |
PeterMD's key differentiator in this comparison is longevity medicine — Metformin, Rapamycin, and Glutathione are not offered by Limitless Alt Med. For patients building a longevity protocol alongside hormone therapy, PeterMD is one of the only telehealth platforms making this stack available. Their track record (founded 2015) and 13,900+ Trustpilot reviews also carry meaningful weight.
Limitless Alt Med differentiates on peptide access. BPC-157, PT-141, and GHK-Cu blends are all available with published pricing and free consultations. Their 95% no-bloodwork policy means patients can access most treatments without the friction of lab requirements. Oral TRT is also available — an option PeterMD doesn't currently publish.
Sermorelin $211/mo, NAD+ $125/mo, TRT from $77/mo annual, Sema $165/mo. Metformin + Rapamycin + Glutathione. Founded 2015. 13,900+ Trustpilot reviews.
BPC-157 $325, PT-141 $184, GHK-Cu, Sermorelin $194, NAD+ $180/vial, TRT $115–$170/mo (oral + injectable). Free consults. 95% no labs required.
PeterMD wins for patients with longevity goals — Metformin, Rapamycin, Glutathione, and a decade of operating history are hard to beat in this tier. Their NAD+ at $125/month and Sema at $165/month also edge out Limitless on those specific protocols.
Limitless Alt Med wins if BPC-157, PT-141, or oral TRT are part of what you need. Free consultations and published pricing make it easier to start, and the 95% no-bloodwork access removes barriers that PeterMD's lab requirements add for some protocols.
Yes — Limitless offers BPC-157 injectable at $325, PT-141 at $184, and GHK-Cu blends. PeterMD does not offer BPC-157 or PT-141; their peptide formulary is limited to Sermorelin and NAD+.
Yes — PeterMD prescribes Metformin, Rapamycin, and Glutathione. Limitless Alt Med does not offer these longevity compounds.
Yes — Limitless Alt Med offers free consultations before any commitment. PeterMD includes consultation in the plan cost. Both are accessible; Limitless removes the financial barrier to initial exploration.